BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 28371345)

  • 21. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
    Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
    Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.
    Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z
    Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1.
    Park KC; Menezes SV; Kalinowski DS; Sahni S; Jansson PJ; Kovacevic Z; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2644-2663. PubMed ID: 29679718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.
    Liu W; Iiizumi-Gairani M; Okuda H; Kobayashi A; Watabe M; Pai SK; Pandey PR; Xing F; Fukuda K; Modur V; Hirota S; Suzuki K; Chiba T; Endo M; Sugai T; Watabe K
    J Biol Chem; 2011 May; 286(21):18949-59. PubMed ID: 21454613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway.
    Sun J; Zhang D; Zheng Y; Zhao Q; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2013 Feb; 83(2):454-69. PubMed ID: 23188716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.
    Tian S; Wang X; Proud CG
    Oncotarget; 2017 Jul; 8(28):46121-46135. PubMed ID: 28545025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
    Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
    Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
    Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
    Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
    Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
    Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
    Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Chang PL; Juang HH
    Prostate; 2012 Sep; 72(13):1431-42. PubMed ID: 22290289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.
    Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR
    Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer.
    Guo J; Yu X; Gu J; Lin Z; Zhao G; Xu F; Lu C; Ge D
    Tumour Biol; 2016 May; 37(5):6371-8. PubMed ID: 26631033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer.
    Wang B; Li J; Ye Z; Li Z; Wu X
    Oncol Rep; 2014 May; 31(5):2279-85. PubMed ID: 24626771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
    Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
    Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels.
    Salvi A; Thanabalu T
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1353-1359. PubMed ID: 27939884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.